Inventor · disambiguated record
Holger Cynis
Also filed as: CYNIS HOLGER
10 granted patents·12 pending applications·24 citations·filing 2007–2025
84Inventor score
Files withPROBIODRUG AG8SCHILLING STEPHAN5FRAUNHOFER GES FORSCHUNG3GRAUBNER SIGRID2VIVORYON THERAPEUTICS N V2
Top patents by PatentIndex Score
22 records- 0185US8129160B2Method of screening for inhibitors of glutaminyl cyclase activitySCHILLING STEPHAN·Filed 2009·Granted Mar 6, 2012·7 cites·19 claims
- 0284US8338120B2Method of treating inflammation with glutaminyl cyclase inhibitorsSCHILLING STEPHAN·Filed 2008·Granted Dec 25, 2012·5 cites·16 claims
- 0380US8283517B2Transgenic mouse models of Aβ overexpressionSCHILLING STEPHAN·Filed 2008·Granted Oct 9, 2012·6 cites·29 claims
- 0478US8889709B2Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditionsDEMUTH HANS-ULRICH·Filed 2009·Granted Nov 18, 2014·4 cites·37 claims
- 0572US2025388544A1Heteroaromatic inhibitors of astacin proteinasesVIVORYON THERAPEUTICS N V·Filed 2025·Application pending·0 cites
- 0670US8647834B2Screening method for enzyme inhibitorsSCHILLING STEPHAN·Filed 2011·Granted Feb 11, 2014·2 cites·19 claims
- 0760US2025163136A1Anti-transthyretin (ttr) binding proteins and uses thereofFRAUNHOFER GES FORSCHUNG·Filed 2023·Application pending·0 cites
- 0859US8518406B2Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)CYNIS HOLGER·Filed 2009·Granted Aug 27, 2013·0 cites·26 claims
- 0959US2008249083A1Novel genes related to glutaminyl cyclasePROBIODRUG AG·Filed 2007·Application pending·0 cites
- 1057US9157918B2Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)PROBIODRUG AG·Filed 2013·Granted Oct 13, 2015·0 cites·7 claims
- 1157US2023122243A1Heteroaromatic inhibitors of astacin proteinasesVIVORYON THERAPEUTICS N V·Filed 2020·Application pending·0 cites
- 1246US2015361167A1Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (mcp-1 n1pe)PROBIODRUG AG·Filed 2015·Application pending·0 cites
- 1345US2008200567A1In vivo screening models for treatment of alzheimer's disease and other qpct-related disordersPROBIODRUG AG·Filed 2008·Application pending·0 cites
- 1444US11703511B2Anti-isoAsp7 amyloid β (Aβ) antibodies and uses thereofFRAUNHOFER GES FORSCHUNG·Filed 2018·Granted Jul 18, 2023·0 cites·16 claims
- 1543US9277737B2Mouse models carrying a knock-out mutation of the QPCTL-genePROBIODRUG AG·Filed 2013·Granted Mar 8, 2016·0 cites·19 claims
- 1641US11958871B2Inhibitors of bacterial glutaminyl cyclases for use in the treatment of periodontal and related diseasesFRAUNHOFER GES FORSCHUNG·Filed 2019·Granted Apr 16, 2024·0 cites·14 claims
- 1741US2012070444A1IN VIVO SCREENING MODELS FOR TREATMENT OF isoQC-RELATED DISORDERSGRAUBNER SIGRID·Filed 2011·Application pending·0 cites
- 1838US2012184518A1Methods of treating or preventing an inflammatory disease or condition using glutaminyl cyclase inhibitorsSCHILLING STEPHAN·Filed 2012·Application pending·0 cites
- 1937US2015150225A1Transgenic mouse expressing human isoglutaminyl cyclotransferasePROBIODRUG AG·Filed 2015·Application pending·0 cites
- 2036US2011212853A1Novel diagnostic methodPROBIODRUG AG·Filed 2011·Application pending·0 cites
- 2133US2013052203A1In vivo screening models for treatment of qc-related disordersGRAUBNER SIGRID·Filed 2012·Application pending·0 cites
- 2230US2010299766A1Mouse models carrying a knock-out mutation of the qpctl-genePROBIODRUG AG·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Holger Cynis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →